Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 37, Pages 15127-15132
Publisher
Proceedings of the National Academy of Sciences
Online
2013-08-27
DOI
10.1073/pnas.1309566110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
- (2013) Glen J. Weiss et al. INVESTIGATIONAL NEW DRUGS
- Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies
- (2012) Razelle Kurzrock et al. CANCER
- Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer Agents
- (2012) W P Caron et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs
- (2012) Gina Song et al. JOURNAL OF LIPOSOME RESEARCH
- Nanotechnology: Carrying drugs
- (2012) Katherine Bourzac NATURE
- Proof of concept for next-generation nanoparticle drugs in humans
- (2012) Cormac Sheridan NATURE BIOTECHNOLOGY
- Companies in footrace to deliver RNAi
- (2012) Aaron Bouchie NATURE BIOTECHNOLOGY
- Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
- (2012) Z. Cheng et al. SCIENCE
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
- (2011) Jinjun Shi et al. ACCOUNTS OF CHEMICAL RESEARCH
- The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles
- (2011) Kai Xiao et al. BIOMATERIALS
- Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer
- (2011) Shikha Gaur et al. Nanomedicine-Nanotechnology Biology and Medicine
- Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
- (2011) H. Cabral et al. Nature Nanotechnology
- Phase I Study of NK012, a Novel SN-38-Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors
- (2010) T. Hamaguchi et al. CLINICAL CANCER RESEARCH
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Strategies in the design of nanoparticles for therapeutic applications
- (2010) Robby A. Petros et al. NATURE REVIEWS DRUG DISCOVERY
- Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
- (2010) Chris Oerlemans et al. PHARMACEUTICAL RESEARCH
- Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin
- (2009) Mark E. Davis ADVANCED DRUG DELIVERY REVIEWS
- Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors
- (2009) W. T. Lim et al. ANNALS OF ONCOLOGY
- Preclinical Results of Camptothecin-Polymer Conjugate (IT-101) in Multiple Human Lymphoma Xenograft Models
- (2009) T. Numbenjapon et al. CLINICAL CANCER RESEARCH
- Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements
- (2009) T. Schluep et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel Delivery of SN38 Markedly Inhibits Tumor Growth in Xenografts, Including a Camptothecin-11-Refractory Model
- (2008) P. Sapra et al. CLINICAL CANCER RESEARCH
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started